Cargando…
Newborn Screening for Mucopolysaccharidosis I: Moving Forward Learning from Experience
There have been significant advances allowing for the integration of mucopolysaccharidosis I into newborn screening programs. Initial experiences using a single-tier approach for this disorder have highlighted shortcomings that require immediate remediation. The recent evaluation of a second-tier bi...
Autores principales: | Clarke, Lorne A., Dickson, Patricia, Ellinwood, N. Matthew, Klein, Terri L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712368/ https://www.ncbi.nlm.nih.gov/pubmed/33227921 http://dx.doi.org/10.3390/ijns6040091 |
Ejemplares similares
-
Arterial Pathology in Canine Mucopolysaccharidosis-I and Response to Therapy
por: Lyons, Jeremiah A., et al.
Publicado: (2011) -
Immune-Mediated Inflammation May Contribute to the Pathogenesis of Cardiovascular Disease in Mucopolysaccharidosis Type I
por: Khalid, Omar, et al.
Publicado: (2016) -
Protein pyrophosphorylation: moving forward
por: Saiardi, Adolfo
Publicado: (2016) -
A pilot newborn screening program for Mucopolysaccharidosis type I in Taiwan
por: Lin, Shuan-Pei, et al.
Publicado: (2013) -
Harmonization of Newborn Screening Results for Pompe Disease and Mucopolysaccharidosis Type I
por: Dorley, M. Christine, et al.
Publicado: (2023)